Kengo Takeuchi
The Cancer Institute Hospital · 683 works · 21,387 citations · h-index 69
Top works
- RET, ROS1 and ALK fusions in lung cancer
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
- Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
- Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer
- EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
- A mouse model for EML4-ALK -positive lung cancer
- CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
- EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
- Frequent inactivation of A20 in B-cell lymphomas
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
- Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients
- Integrated molecular analysis of adult T cell leukemia/lymphoma
- Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib
- Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis
- KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only
- Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma
- Identification of anaplastic lymphoma kinase fusions in renal cancer
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations